Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Summary of Product Characteristics last updated on the eMC: 31/08/2011
SPC Mercilon

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 31/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 4.7 - Effects on Ability to Drive and Use Machines
  • Change to section 10 date of revision of the text
Date of revision of text on the SPC:   31-May-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

In section 4.7 (Effects on ability to drive and use of machines)
Wording has been chnaged from "none stated" to "No observed effects"

Updated on 30/09/2002 and displayed until 31/08/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/08/2001 and displayed until 30/09/2002
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   ethinylestradiol
   desogestrel